Several revolutionary therapies are now accessible in the United Kingdom for treating diabetes type 2 . Saxenda, Rybelsus , and Trulicity represent unique approaches, with copyright and Mounjaro being injectable GLP-1 receptor agonists primarily aimed at slimming alongside sugar levels control ,